Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0546 Transporter Info | ||||
Gene Name | KCNK9 | ||||
Transporter Name | Potassium channel subfamily K member 9 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Fluoxetine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Fluoxetine inhibits the activity of KCNK9 | [1] | |||
Cell System |
Human embryonic kidney 293 cells (HEK293)-KCNK9 | ||||
Calcitriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Calcitriol increases the expression of KCNK9 | [2] | |||
Methotrexate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methotrexate inhibits the expression of KCNK9 | [3] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valproic Acid increases the expression of KCNK9 | [4] | |||
Patented Pharmaceutical Agent |
|||||
NSC-689534 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
NSC-689534 increases the expression of KCNK9 | [5] | |||
Health and Environmental Toxicant |
|||||
Butyraldehyde |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Butyraldehyde increases the expression of KCNK9 | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.